Motivational Interviewing Applied to Individuals With Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorBozok University
About this trial
This study will be conducted using a randomized controlled trial design to evaluate the effect of online individual motivational interviewing on well-being, stress and difficulties in individuals with diabetes. The study will be conducted between March 2024 and March 2025 with individuals with Type 2 Diabetes who are followed up in Yozgat Bozok University Health Practice and Research Center Internal Medicine Polyclinic. The motivational interview group will receive a motivational interview once a week, lasting a maximum of 40 minutes, consisting of a total of four sessions. Chi-square (X2), t-test, repeated measures analysis of variance, Pearson correlation coefficient, partial eta-square and linear regression analysis will be used to evaluate the data.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
volunteering to participate in the study,
Having a diagnosis of Type 2 Diabetes,
HbA1C values outside the normal range for the last 2-3 months.
Disqualifiers
Having a diagnosis of Type 1 Diabetes,
Having limitations in reading and understanding Turkish.
Trial design
Design model
Parallel
Treatments tested in this trial
motivational interview
BehavioralMotivational interviewing will be conducted in four sessions and the session duration will be maximum 40 minutes. The session will be conducted individually and online once a week. For the individual interview, the appropriate day and time will be determined with the individuals with diabetes and the researcher before the first session and the sessions will continue on the same day and time every week. The researcher will remind the participant about the time of the session by calling the participant by phone one day before each session. Motivational interview sessions will be held online on the Whatsapp platform.
Treatment groups
66 Participants
are divided into 2 treatment groupsGroup A: Motivational InterviewingExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in coping with stress
This scale will be administered twice before and after the intervention to determine the patients' coping methods with stress. The scale consists of three sub-dimensions: problem-focused coping (8 items), social support-focused coping (7 items) and avoidance-focused coping (8 items). The scale consists of a total of 23 items, 20 of which are positively worded and three items (items 10, 17, 20) are negatively worded. A score of 23-115 can be obtained from the whole scale. The higher the score obtained from the whole scale and subscales reflects the tendency of the person to use the relevant ways of coping with stress.
Time frame
4 weeksSecondary outcomes
1
State of Well-Being Change
The scale consists of 5 items containing 5 positive statements about the participant's emotions in the last 2 weeks. Each item is evaluated on a 6-point Likert-type scale ranging from 0-5; a score of 0 indicates no positive emotions in the last 2 weeks, while a score of 5 indicates continuous positive emotions. Raw scores are converted into a scoring scale between 0-10. A score below 50 indicates low mood.
Time frame
4 weeksOther outcomes
1
Changing Strength and Difficulties in Diabetes
As a result of the factor analysis, the scale of strengths and difficulties in type 2 diabetes consisted of 3 sub-dimensions and 30 items in total. Each item in the scale is in 5-point Likert type and the minimum score that can be obtained from the scale is 30 and the maximum score is 150. There are no reverse items in the scale. An increase in the score obtained from the scale indicates that the difficulties experienced by individuals with type 2 diabetes increase.
Time frame
4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov